Eprosartan
From Wikipedia, the free encyclopedia
 |
|
|
Eprosartan
|
|
| Systematic (IUPAC) name | |
| 4-[[2-butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-
imidazol-1-yl]methyl]benzoic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | C09 ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C23H24N2O4S |
| Mol. mass | Eprosartan mesylate: 520.625 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 5 to 9 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
? |
| Routes | Oral |
Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed as Teveten® by the Biovail Corporation in the United States and by Solvay Pharmaceuticals elsewhere. It is sometimes paired with hydrochlorothiazide.
The drug acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure.
As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than ACE inhibitors, especially among the elderly.
[edit] External links
- Teveten (manufacturer's webdite)
- Eprosartan (patient information)
Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Tasosartan, Telmisartan, Valsartan
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
